We hosted a free webinar on how you can overcome the challenges of biosimilars and help your brand develop counter-biosimilar messaging strategies on Thursday, February 26th, as part of our monthly SKIM webinar sessions. Feel free to review the webinar via the webcast and/or slide deck below.
Counter-biosimilar messaging: protect your brand
Presented by:
Nicole Drake, Director Client Solutions Healthcare
Mike Mabey, VP Client Solutions Americas
Alex Zhu, Manager
Please note that loading the webcast on this webpage might take some time due to the length of the video. If it takes too long, it might be helpful to click here to view the video on youtube.com.
If you are unable to view the slides on this page or you’d like to download the presentation file, click here to view our slides on SlideShare.
About the webinar
Biosimilars are an inevitable force in pharma. The introduction of biosimilars may be a major threat to the branded product. One of the challenges for biologics at the end of their patent protection is how to communicate the tangible and/or emotional benefits of the branded product in the face of assumed (and real) price differences with biosimilars.
In today’s pharmaceutical industry, this communication has become a more and more important part of brand’s strategy to defend the competition from biosimilars. Even a delay of a few months for the uptake of biosimilar could have significant financial impact. For well-established brands, it also represents an opportunity to leverage brand equity to communicate to key stakeholders including physicians, patients and key influencers such as nurses and physician assistants.
Alex, Nicole, and Mike utilized a case study to illustrate how we address this challenge to help brands develop counter-biosimilar messaging strategies.